The nation of Zimbabwe has turned down a significant US health deal valued at 367 million US dollars (£272m) spanning five years over the United States' demand for confidential data.
The decision became public following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson later explained that the US was seeking genetic material for scientific study and profit but was unwilling to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further negotiations to find a agreement agreeable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Context
This development follows a similar situation in Kenya, where a high court halted a related deal with the US following concerns were raised about the security of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.
As per statements, 16 nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our country would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our population should a future pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the American exit from the global health body and its push of one-on-one deals were upending systems already set up via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This system is designed to ensure that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to continued dialogue with our US partners on how subsequent collaboration might be arranged in a manner that honours the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that negotiations should continue since a large portion of the nation's HIV programmes were funded by external financing.
"If specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group commented.
The halted deal highlights the continuing debate between accepting much-needed foreign assistance and protecting a country's data in an ever more interconnected world.